These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 32515129

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC, Oliver AG, Markley LD, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3493-8. PubMed ID: 24909079
    [Abstract] [Full Text] [Related]

  • 4. In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis.
    Venugopala KN, Tratrat C, Pillay M, Chandrashekharappa S, Al-Attraqchi OHA, Aldhubiab BE, Attimarad M, Alwassil OI, Nair AB, Sreeharsha N, Venugopala R, Morsy MA, Haroun M, Kumalo HM, Odhav B, Mlisana K.
    Drug Des Devel Ther; 2020 Aug 01; 14():1027-1039. PubMed ID: 32214795
    [Abstract] [Full Text] [Related]

  • 5. Design, synthesis and biological activity of N-(2-phenoxy)ethyl imidazo[1,2-a]pyridine-3-carboxamides as new antitubercular agents.
    Wang A, Lv K, Li L, Liu H, Tao Z, Wang B, Liu M, Ma C, Ma X, Han B, Wang A, Lu Y.
    Eur J Med Chem; 2019 Sep 15; 178():715-725. PubMed ID: 31229874
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR, Lun S, Payne A, Bishai WR, Gunosewoyo H.
    Bioorg Chem; 2021 Jan 15; 106():104486. PubMed ID: 33276981
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H, Wang A, Gu J, Fu L, Lv K, Ma C, Tao Z, Wang B, Liu M, Guo H, Lu Y.
    Eur J Med Chem; 2019 Mar 01; 165():11-17. PubMed ID: 30654236
    [Abstract] [Full Text] [Related]

  • 8. Linked pyridinyl-thiadiazoles: Design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis.
    Mahajan NS, Dhawale SC.
    Eur J Med Chem; 2015 Sep 18; 102():243-8. PubMed ID: 26280920
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Lv K, Li L, Wang B, Liu M, Wang B, Shen W, Guo H, Lu Y.
    Eur J Med Chem; 2017 Sep 08; 137():117-125. PubMed ID: 28577507
    [Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J, Xu J, Zhang G, Xu C, Zhao L, You X, Wang Y, Lu Y, Yu L, Wang J.
    Bioorg Med Chem Lett; 2019 Feb 15; 29(4):539-543. PubMed ID: 30630715
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Patel H, Chaudhari K, Jain P, Surana S.
    Bioorg Chem; 2020 Sep 15; 102():104099. PubMed ID: 32711084
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and Biological Evaluation of Hybrid 1,5- and 2,5-Disubstituted Indoles as Potentially New Antitubercular Agents.
    Soares A, Estevao MS, Marques MMB, Kovalishyn V, Latino DARS, Aires-de-Sousa J, Ramos J, Viveiros M, Martins F.
    Med Chem; 2017 Sep 15; 13(5):439-447. PubMed ID: 28185538
    [Abstract] [Full Text] [Related]

  • 13. Preparation and Evaluation of Potent Pentafluorosulfanyl-Substituted Anti-Tuberculosis Compounds.
    Moraski GC, Bristol R, Seeger N, Boshoff HI, Tsang PS, Miller MJ.
    ChemMedChem; 2017 Jul 20; 12(14):1108-1115. PubMed ID: 28654200
    [Abstract] [Full Text] [Related]

  • 14. Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent.
    Kang S, Kim RY, Seo MJ, Lee S, Kim YM, Seo M, Seo JJ, Ko Y, Choi I, Jang J, Nam J, Park S, Kang H, Kim HJ, Kim J, Ahn S, Pethe K, Nam K, No Z, Kim J.
    J Med Chem; 2014 Jun 26; 57(12):5293-305. PubMed ID: 24870926
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M, Wan B, Cho S, Franzblau SG, Costantino G.
    Eur J Med Chem; 2014 Jan 24; 72():26-34. PubMed ID: 24333612
    [Abstract] [Full Text] [Related]

  • 17. Pyridine and nitro-phenyl linked 1,3,4-thiadiazoles as MDR-TB inhibitors.
    Patel H, Jadhav H, Ansari I, Pawara R, Surana S.
    Eur J Med Chem; 2019 Apr 01; 167():1-9. PubMed ID: 30743094
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN, Chandrashekharappa S, Pillay M, Bhandary S, Kandeel M, Mahomoodally FM, Morsy MA, Chopra D, Aldhubiab BE, Attimarad M, Alwassil OI, Harsha S, Mlisana K, Odhav B.
    Med Chem; 2019 Apr 01; 15(3):311-326. PubMed ID: 29968540
    [Abstract] [Full Text] [Related]

  • 19. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D, Yogeeswari P, Dinakaran M, Thirumurugan R.
    J Antimicrob Chemother; 2007 Jun 01; 59(6):1194-6. PubMed ID: 17449482
    [Abstract] [Full Text] [Related]

  • 20. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH, Borges-Argáez R, Said-Fernández S, Vargas-Villarreal J, González-Salazar F, Méndez-González M, Cáceres-Farfán M, Molina-Salinas GM.
    Pulm Pharmacol Ther; 2014 Feb 01; 27(1):114-20. PubMed ID: 23968826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.